Stay updated with breaking news from Patrickr Oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) – Investment analysts at William Blair cut their Q3 2023 earnings estimates for Ionis Pharmaceuticals in a report issued on Wednesday, August 9th. William Blair analyst M. Minter now expects that the company will post earnings of ($0.95) per share for the quarter, down from their previous forecast […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has earned a consensus recommendation of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have given a buy recommendation to the company. […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 8,690,000 shares, a growth of 33.3% from the May 31st total of 6,520,000 shares. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 8,690,000 shares, a growth of 33.3% from the May 31st total of 6,520,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the days-to-cover ratio […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 8,690,000 shares, an increase of 33.3% from the May 31st total of 6,520,000 shares. Based on an average daily volume of 1,210,000 shares, the short-interest ratio is […]